We further present evidence that the upregulation of HOXB13 in MPE (and in cauda equina neuroendocrine tumors) is likely due to differential HOXB13-associated CpG site methylation when compared to SP-EP. This evidence concerns the gene HOXB13 and neuroendocrine neoplasm.